A Clinical, Regulatory & Operational Readiness Self-Assessment for sponsors planning a structural heart or coronary clinical trial in Europe.
Important: This checklist provides a non-binding, informational readiness assessment only. It does not constitute regulatory advice or a conformity assessment under applicable EU regulations.
Entering Europe for a structural heart or coronary clinical trial is a significant milestone. The difference between a smooth study launch and a delayed, resource-intensive one often comes down to preparation.
Evaluate feasibility, site selection, and imaging or endpoint preparedness for structural heart and coronary studies.
Assess MDR alignment, country-specific pathways, ethics timelines, and indemnification considerations.
Review contracting, monitoring strategy, device logistics, long-term follow-up, and local expertise.
This checklist is designed to help sponsors assess whether they are truly ready to initiate a structural heart or coronary trial in Europe. It is not simply a regulatory exercise. It is an operational, strategic, and clinical readiness assessment based on the reality of the European environment.
If several of these areas remain unclear or unresolved, it is usually a sign that additional planning and experienced regional support may be needed before moving forward.
Read the criteria listed under each of the 7 areas, then select the answer that best reflects your current readiness. At the end, your total score identifies your EU readiness tier.
Maximum score: 21 points across 7 questions.
Strong readiness. This area is addressed, documented, and operationally ready.
Minor gaps remain. Core elements are in place but some details need to be resolved.
Significant gaps exist. This area has been started but is not yet operationally ready.
This area has not yet been formally assessed or planned.
Complete the 5-minute checklist to receive your readiness tier and a per-area breakdown across regulatory, clinical, and operational dimensions.